> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Public Citizen Wants Gabapentin Scheduled
- URL: https://www.fdaweb.com/public-citizen-wants-gabapentin-scheduled/
- Published: 2022-02-10T12:00:00.000Z
- Updated: 2026-09-14T17:32:09.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5151140

Public Citizen is petitioning FDA and the Drug Enforcement Administration to open proceedings to place gabapentin (Almatica Pharma’s Gralise and Pfizer’s Neurontin) and gabapentin enacarbil (Arbor’s Horizant) into Schedule V of the Controlled Substances Act. The [petition](https://downloads.regulations.gov/FDA-2022-P-0149-0001/attachment%5F1.pdf?ref=fdaweb.com) says scheduling the drugs is necessary because they have a “marked potential for abuse with serious consequences that include psychological effects, physical dependence, seizures, suicide, and overdose death.”

The petition says FDA has approved gabapentin to treat specific forms of epilepsy and neuropathic pain. Gabapentin enacarbil is approved for the treatment of primary restless legs syndrome and postherpetic neuralgia.

“There is now extensive evidence documenting the abuse potential of gabapentin and increasing misuse, abuse, and dependence of the drug,” Public Citizen says.